These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9885990)
1. Effects of melatonin on proliferation of cancer cell lines. Papazisis KT; Kouretas D; Geromichalos GD; Sivridis E; Tsekreli OK; Dimitriadis KA; Kortsaris AH J Pineal Res; 1998 Dec; 25(4):211-8. PubMed ID: 9885990 [TBL] [Abstract][Full Text] [Related]
2. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Blask DE; Wilson ST; Zalatan F Cancer Res; 1997 May; 57(10):1909-14. PubMed ID: 9157984 [TBL] [Abstract][Full Text] [Related]
3. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Hill SM; Blask DE Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858 [TBL] [Abstract][Full Text] [Related]
4. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Hill SM; Spriggs LL; Simon MA; Muraoka H; Blask DE Cancer Lett; 1992 Jul; 64(3):249-56. PubMed ID: 1638517 [TBL] [Abstract][Full Text] [Related]
5. Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system. Cos S; Blask DE Cancer Lett; 1990 Apr; 50(2):115-9. PubMed ID: 2328480 [TBL] [Abstract][Full Text] [Related]
6. Melatonin's inhibitory effect on growth of ME-180 human cervical cancer cells is not related to intracellular glutathione concentrations. Chen LD; Leal BZ; Reiter RJ; Abe M; Sewerynek E; Melchiorri D; Meltz ML; Poeggeler B Cancer Lett; 1995 May; 91(2):153-9. PubMed ID: 7767904 [TBL] [Abstract][Full Text] [Related]
7. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells. Baldwin WS; Travlos GS; Risinger JI; Barrett JC Carcinogenesis; 1998 Nov; 19(11):1895-900. PubMed ID: 9854999 [TBL] [Abstract][Full Text] [Related]
8. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572 [TBL] [Abstract][Full Text] [Related]
9. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Cos S; Recio J; Sánchez-Barceló EJ Life Sci; 1996; 58(9):811-6. PubMed ID: 8632728 [TBL] [Abstract][Full Text] [Related]
10. Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells. Panzer A; Lottering ML; Bianchi P; Glencross DK; Stark JH; Seegers JC Cancer Lett; 1998 Jan; 122(1-2):17-23. PubMed ID: 9464486 [TBL] [Abstract][Full Text] [Related]
11. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876 [TBL] [Abstract][Full Text] [Related]
12. 5-Fluorouracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cells (MCF7). Furuya Y; Yamamoto K; Kohno N; Ku Y; Saitoh Y Cancer Lett; 1994 Jun; 81(1):95-8. PubMed ID: 8019993 [TBL] [Abstract][Full Text] [Related]
13. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7. Czeczuga-Semeniuk E; Wołczyński S; Anchim T; Dziecioł J; Dabrowska M; Pietruczuk M Pol J Pathol; 2002; 53(2):59-65. PubMed ID: 12140868 [TBL] [Abstract][Full Text] [Related]
14. Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cos S; Sánchez-Barceló EJ Cancer Lett; 1995 Jul; 93(2):207-12. PubMed ID: 7621430 [TBL] [Abstract][Full Text] [Related]
15. Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro. Wilson ST; Blask DE; Lemus-Wilson AM J Clin Endocrinol Metab; 1992 Aug; 75(2):669-70. PubMed ID: 1639964 [TBL] [Abstract][Full Text] [Related]
16. Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. Dai J; Inscho EW; Yuan L; Hill SM J Pineal Res; 2002 Mar; 32(2):112-9. PubMed ID: 12071468 [TBL] [Abstract][Full Text] [Related]
17. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668 [TBL] [Abstract][Full Text] [Related]
18. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. Blask DE; Hill SM J Neural Transm Suppl; 1986; 21():433-49. PubMed ID: 3462341 [TBL] [Abstract][Full Text] [Related]
19. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Chen G; Waxman DJ Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907 [TBL] [Abstract][Full Text] [Related]
20. Transient inhibition of synergistically insulin-like growth factor-1- and bisphenol A-induced poliferation of estrogen receptor alpha (ERalpha)-positive human breast cancer MCF-7 cells by melatonin. Ishido M Environ Sci; 2004; 11(3):163-70. PubMed ID: 15750583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]